Emerging studies suggest Retatru tide , a dual agonist targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , could offer a notable step forward for body loss . https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide